Evaluation of the Effect of an APP in Improving Treatment Adherence in Hypertensive Patients in Hypertension Ambulatory

NCT ID: NCT04475367

Last Updated: 2020-07-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-07-10

Study Completion Date

2021-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Brief Summary: Through the App, the user will have the opportunity to connect directly with the health professional, clarify doubts and manage the treatment of their hypertension.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To evaluate treatment adherence and blood pressure reduction, through the HiperCross App, between two groups of hypertensive patients in a Hypertension Public Ambulatory in Porto Alegre.

The investigators hope to identify better adherence to treatment, as well as a significant reduction in blood pressure, all of these results will be better evaluated using the HiperCross application.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Pressure Adhesion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The participants will be randomized into 2 intervention groups
Primary Study Purpose

SCREENING

Blinding Strategy

SINGLE

Outcome Assessors
blind research assistant

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hypertensive patients using HyperCrossApp

Interdisciplinary health care

\+ HyperCross App

Group Type EXPERIMENTAL

App hypercross group

Intervention Type OTHER

hypertensive patients using HyperCrossApp

hypertensive patients without using HyperCrossApp

Interdisciplinary health care

Group Type ACTIVE_COMPARATOR

without App hypercross group

Intervention Type OTHER

Interdisciplinary health care

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

App hypercross group

hypertensive patients using HyperCrossApp

Intervention Type OTHER

without App hypercross group

Interdisciplinary health care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* hypertensive patients admitted to the hypertension clinic at Instituto de Cardiologia
* older 18 years

Exclusion Criteria

* Patients without a mobile phone compatible with the App
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Instituto de Cardiologia do Rio Grande do Sul

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ana Paula Reis

Nurse Specialist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bruna Eibel, PhD

Role: STUDY_DIRECTOR

Post Graduation professor - Cardiology Foundation

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ana Paula Reis, Nurse

Role: CONTACT

+555132303600

Bruna Eibel, PhD

Role: CONTACT

+555132303600

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5701-19

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Text My Hypertension BP Meds NOLA
NCT05074173 COMPLETED NA